Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-27 @ 2:32 AM
Study NCT ID:
NCT00788593
Status:
COMPLETED
Last Update Posted:
2014-03-12
First Post:
2008-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)
Sponsor:
Forest Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-03
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-10
First Submit QC Date:
None
Study First Post Date:
2008-11-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-27
Results First Submit QC Date:
None
Results First Post Date:
2014-03-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-27
Last Update Post Date:
2014-03-12
Last Update Post Date Type:
ESTIMATED